What is the debt of Qiagen this year?
Qiagen has a debt level of 841.71 USD this year.
Qiagen Debt 2024
Qiagen Debt
841.71 USD
Ticker
QGEN
ISIN
NL0012169213
WKN
A2DKCH
In 2024, Qiagen's total debt was 841.71 USD, a -25.56% change from the 1,130.78 USD total debt recorded in the previous year.
Qiagen Aktienanalyse
What does Qiagen do?
Qiagen NV is a biotechnology company based in Venlo, Netherlands. The company was founded in 1984 as a spin-off from the University of Düsseldorf and has since become a leading provider of molecular diagnostic products and systems. Qiagen operates in four business areas: Life Sciences, Molecular Diagnostics, Applied Testing, and Pharma. Life Sciences is the largest business area of the company and offers a wide range of products for DNA sequencing, gene expression, RNA isolation and analysis, as well as protein analysis. Molecular Diagnostics specializes in diagnostic tests for diseases such as cancer, infections, and genetic disorders. Applied Testing provides solutions for forensic analysis and food and environmental analysis, while Pharma offers products and services for drug discovery and development. In recent years, Qiagen has focused mainly on the development of molecular diagnostic tests for cancer and infection-related diseases such as HIV, hepatitis, and tuberculosis. These tests enable earlier detection of diseases and more targeted therapy, improving patient care and reducing healthcare costs. One example of a successful Qiagen product is the Cobas HPV Test, a molecular diagnostic test for the detection of human papillomaviruses (HPV) responsible for cervical cancer. The test is distributed by Roche Diagnostics and is one of the best-selling molecular diagnostic tests in the world. Qiagen also has a strong presence in academic research and is a major provider of tools and technologies for DNA sequencing and genome research. Customers include leading research institutes, universities, and pharmaceutical companies. In recent years, Qiagen has also expanded through acquisitions to expand its offering of products and technologies and enter new markets. For example, in 2018, the company acquired N-of-One, a provider of artificial intelligence in cancer diagnostics, and NeuMoDx Molecular, a provider of molecular diagnostic platforms for laboratories. In 2020, Qiagen also played a crucial role in the development of tests for the new coronavirus (SARS-CoV-2). The company, together with other leading diagnostic companies, developed molecular diagnostic tests for rapid and reliable diagnosis of COVID-19. Overall, Qiagen is an important player in the biotech industry, offering a wide range of products and services for molecular diagnostics, genome research, and pharmaceutical research. Qiagen has a strong competitive position due to its innovative products and technologies, strong presence in academic research, and strategic acquisitions to expand its product portfolio and market access. Qiagen ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Qiagen's Debt Structure
Qiagen's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Qiagen's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Qiagen’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Qiagen’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Qiagen stock
What was the debt of Qiagen compared to the previous year?
The debt of Qiagen has increased by -25.56% compared to the previous year dropped.
What are the consequences of high debt for investors in Qiagen?
High debt can pose a risk for investors of Qiagen, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Qiagen?
Low debt means that Qiagen has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Qiagen affect the company?
An increase in debt of Qiagen can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Qiagen affect the company?
A reduction in debt of Qiagen can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Qiagen?
Some factors that can influence the debt of Qiagen include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Qiagen so important for investors?
The debts of Qiagen are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Qiagen take to change the debt?
To change the debt, Qiagen can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Qiagen pay?
Over the past 12 months, Qiagen paid a dividend of 1.08 USD . This corresponds to a dividend yield of about 2.4 %. For the coming 12 months, Qiagen is expected to pay a dividend of 14.01 USD.
What is the dividend yield of Qiagen?
The current dividend yield of Qiagen is 2.4 %.
When does Qiagen pay dividends?
Qiagen pays a quarterly dividend. This is distributed in the months of February, February, February, February.
How secure is the dividend of Qiagen?
Qiagen paid dividends every year for the past 5 years.
What is the dividend of Qiagen?
For the upcoming 12 months, dividends amounting to 14.01 USD are expected. This corresponds to a dividend yield of 31.12 %.
In which sector is Qiagen located?
Qiagen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Qiagen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Qiagen from 2/1/2024 amounting to 1.32 USD, you needed to have the stock in your portfolio before the ex-date on 1/30/2024.
When did Qiagen pay the last dividend?
The last dividend was paid out on 2/1/2024.
What was the dividend of Qiagen in the year 2023?
In the year 2023, Qiagen distributed 0 USD as dividends.
In which currency does Qiagen pay out the dividend?
The dividends of Qiagen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Qiagen stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Qiagen
Our stock analysis for Qiagen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Qiagen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.